Five oral-access pages with exact-product questions
Tablets, compounds and liquids are not one category of medicine.
These pages describe oral options or oral access within a wider catalog. The named preparation and regulatory status still need to be identified. CoreAge’s separate featured commercial offer concerns compounded semaglutide and tirzepatide pathways; it is not a branded oral Wegovy listing.
Separate the membership from the prescription bill
Cost detail
Membership $39 first month, then $149/month; medicine extra
Keep in mind
The page advertises $39 for the first month and $149 for subsequent monthly membership. It also shows lower monthly equivalents for prepaid commitments: $74 with twelve months, $89 with six months and $99 with three months. A monthly equivalent is a way to divide an upfront bill; it does not mean that amount is charged separately each month under the annual option.
Wegovy pill from $149; separate membership $39 then $149
Keep in mind
The page lists a starting $149 medication figure for Wegovy pill, alongside a membership advertised at $39 for the first month and $149 afterward. Reading only the medication number would understate the described recurring arrangement. Any comparison should identify the actual pill offer, the membership term and other applicable costs rather than displaying a single attractive number without its unit.
Program names change both price and what is included
Cost detail
GLP-1Rx $129 start, then $249/month billed quarterly
Keep in mind
The GLP-1Rx program lists $129 to start and $249 per month after the initial four-week supply, billed quarterly. Plus lists $149 to start and $299 per month afterward, also quarterly. Microdose lists $49 to start and $179 per month afterward. Those figures should not be reduced to a single Noom price; the later bill and program selection matter more than the cheapest opening headline.
A medication-card figure is not automatically a complete plan total
Cost detail
Medication cards from $60 semaglutide and $90 tirzepatide
Keep in mind
The current page shows compounded semaglutide from $60, tirzepatide from $90 and a semaglutide pill from $62, alongside other oral choices. These are medication-card starting figures. The opening material reviewed does not establish a complete, universal membership-plus-medicine total. Comparing one of those figures with another company’s bundled program price would mix different units of purchase.
The platform itself is not the healthcare provider
Cost detail
Selected medicine and recurring-plan total need clarification
Keep in mind
FuturHealth says the platform is not itself the healthcare-services provider. Clinical decisions belong to the relevant providers. A prospective customer should understand which practice evaluates them and handles medication questions after enrollment. The platform’s scheduling, billing and digital features are important, but they are not the same responsibilities as prescribing and clinical follow-up.